Cargando…
Effect of Tyrosin Kinase Inhibitors on NK Cell and ILC3 Development and Function
Tyrosin kinase inhibitors (TKI) sharply improved the prognosis of Chronic Myeloid Leukemia (CML) and of Philadelphia(+) Acute Lymphoblastic Leukemia (Ph(+)ALL) patients. However, TKI are not curative because of the development of resistance and lack of complete molecular remission in the majority of...
Autores principales: | Damele, Laura, Montaldo, Elisa, Moretta, Lorenzo, Vitale, Chiara, Mingari, Maria Cristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6207002/ https://www.ncbi.nlm.nih.gov/pubmed/30405627 http://dx.doi.org/10.3389/fimmu.2018.02433 |
Ejemplares similares
-
NK Cells and Other Innate Lymphoid Cells in Hematopoietic Stem Cell Transplantation
por: Vacca, Paola, et al.
Publicado: (2016) -
EZH1/2 Inhibitors Favor ILC3 Development from Human HSPC-CD34(+) Cells
por: Damele, Laura, et al.
Publicado: (2021) -
Human NK Cells: From Surface Receptors to the Therapy of Leukemias and Solid Tumors
por: Moretta, Lorenzo, et al.
Publicado: (2014) -
Unique Eomes(+) NK Cell Subsets Are Present in Uterus and Decidua During Early Pregnancy
por: Montaldo, Elisa, et al.
Publicado: (2016) -
Killer Ig-Like Receptors (KIRs): Their Role in NK Cell Modulation and Developments Leading to Their Clinical Exploitation
por: Pende, Daniela, et al.
Publicado: (2019)